← Evidence map

ArticlePloS one2019

Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines.

Ryoko Takei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

56 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31577826